Axon Enterprise, INC 13F institutional holdings
Quarterly disclosures of US equity positions held by institutional managers with over $100 million under management.
NASDAQ
Axon Enterprise, Inc. reported 1 holdings worth $19.1M for the period ended June 30, 2026.
NASDAQ
Axon Enterprise, Inc. filed its quarterly Form 13F, disclosing its investment holdings as of March 31, 2026, with a total reported value of $18,051,979.
NASDAQ
Axon Enterprise, Inc. has filed its Q3 2025 13F-HR report, revealing a significant holding of 3.68 million ordinary shares in Cellebrite DI Ltd valued at over $68 million.
NASDAQ
Axon Enterprise, Inc. reported its Q2 2025 institutional holdings, revealing a significant stake in Cellebrite DI Ltd. ordinary shares.
NASDAQ
Axon Enterprise, Inc. reports holding $174.87 million in Cellebrite DI Ltd. as of March 31, 2025.
NASDAQ
Axon Enterprise, Inc. reports holding $198.3 million in Cellebrite DI Ltd. Ordinary Shares as of December 31, 2024.